Clinical Trial Update: Cannabis as a Complementary Treatment in Multiple Sclerosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is investigating cannabis as a complementary treatment for multiple sclerosis; the study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Cannabis (Cannabis)

Snippet

Sponsor: Centre hospitalier de l'Université de Montréal (CHUM) | Conditions: Multiple Sclerosis | Phase 2 | Status: RECRUITING